DOCSLIB.ORG

Annual Report 2020 Annual Report 2020

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annual Report 2020 Annual Report 2020 Medical Faculty, University of Bern, Switzerland Medical Faculty, Medical Faculty www.medizin.unibe.ch Annual Report 2020 Annual Report 2020 3 4 Contents Foreword ...................................................................................................................................................................... 7 Highlights 2020 ........................................................................................................................................................... 8 The Medical Faculty in Numbers ............................................................................................................................22 Historical Glimpses of the History of the Faculty .................................................................................................................26 Deans of the Medical Faculty ..................................................................................................................................29 Key People and Institutions Organigram .................................................................................................................................................................32 Board of Faculty .........................................................................................................................................................33 Institutional Overview ..............................................................................................................................................34 Structural Development of the Inselspital Area .................................................................................................36 Dean’s Office ...............................................................................................................................................................40 Dean’s Office of Student‘s Affairs ..........................................................................................................................41 Interview with Prof. Dr. med. et phil. Lia Bally .....................................................................................................42 Interview with Prof. Dr. med. Matthias Egger, MSc FFPH DTM&H .................................................................46 Honorary Doctorate of the Medical Faculty ........................................................................................................50 Highly Cited Researchers 2020 ..............................................................................................................................51 New Professors at the Medical Faculty .................................................................................................................52 In memoriam: Prof. Dr. Annette Draeger .............................................................................................................58 Teaching School of Human Medicine .....................................................................................................................................62 School of Dental Medicine ......................................................................................................................................64 Local Student Committee of Bernese Medical Students .................................................................................66 Student's experiences under CoViD-19 ...............................................................................................................68 Teacher of the Year 2020: Pascal Küpfer ..............................................................................................................69 Bachelor and Master Program in Pharmacy ........................................................................................................70 Starting in fall 2021 ...................................................................................................................................................72 Master of Science Program in Artificial Intelligence in Medicine ...................................................................72 Master Program in Biomedical Sciences ..............................................................................................................74 Master of Science in Biomedical Engineering ....................................................................................................76 Promotion of Young Academics sitem-insel School for Translation and Entrepreneurship in Medicine ........................................................80 CAS, DAS and MAS Degree Programs ..................................................................................................................82 PhD Education ............................................................................................................................................................84 Commission for Equality ..........................................................................................................................................86 Grants ...........................................................................................................................................................................88 5 Centers and Platforms ARTORG Center for Biomedical Engineering Research ....................................................................................92 Center for Artificial Intelligence in Medicine (CAIM) ........................................................................................94 Department for BioMedical Research (DBMR) ...................................................................................................96 Bern Center for Precision Medicine (BCPM) ........................................................................................................98 Department of Clinical Research ........................................................................................................................ 100 Microscopy Imaging Center (MIC)...................................................................................................................... 102 Swiss Institute for Translational and Entrepreneurial Medicine (sitem-insel) .......................................... 104 University Cancer Center (UCI) ............................................................................................................................ 106 University Neurocenter.......................................................................................................................................... 108 Institutes at the Medical Faculty of Bern Institute of Anatomy .............................................................................................................................................. 112 Institute of Biochemistry and Molecular Medicine (IBMM) .......................................................................... 114 Institute for the History of Medicine (IMG) ...................................................................................................... 116 Institute of Pharmacology (PKI) ........................................................................................................................... 118 Institute of Physiology ........................................................................................................................................... 120 Institute of Social and Preventive Medicine (ISPM) ........................................................................................ 122 Theodor Kocher Institute (TKI) ............................................................................................................................ 124 Institute for Infectious Diseases (IFIK) ................................................................................................................ 126 Institute of Pathology ............................................................................................................................................ 128 Institute of Forensic Medicine (IRM) .................................................................................................................. 130 Institute of Dental Medicine (ZMK) .................................................................................................................... 132 Institute of Primary Health Care (BIHAM) ......................................................................................................... 134 Institute of Complementary and Integrative Medicine (IKIM) .................................................................... 136 Institute for Medical Education (IML) ................................................................................................................ 138 Clinics at the University Hospital, Inselspital Department of Anaesthesiology and Pain Medicine ..................................................................................... 142 Department of Angiology .................................................................................................................................... 144 Department of Cardiology ................................................................................................................................... 146 Department of Cardiovascular Surgery ............................................................................................................. 148 Department of Clinical Chemistry .....................................................................................................................
Load more

Recommended publications
  • Us 2018 / 0296525 A1
    UN US 20180296525A1 ( 19) United States (12 ) Patent Application Publication (10 ) Pub. No. : US 2018/ 0296525 A1 ROIZMAN et al. ( 43 ) Pub . Date: Oct. 18 , 2018 ( 54 ) TREATMENT OF AGE - RELATED MACULAR A61K 38 /1709 ( 2013 .01 ) ; A61K 38 / 1866 DEGENERATION AND OTHER EYE (2013 . 01 ) ; A61K 31/ 40 ( 2013 .01 ) DISEASES WITH ONE OR MORE THERAPEUTIC AGENTS (71 ) Applicant: MacRegen , Inc ., San Jose , CA (US ) (57 ) ABSTRACT ( 72 ) Inventors : Keith ROIZMAN , San Jose , CA (US ) ; The present disclosure provides therapeutic agents for the Martin RUDOLF , Luebeck (DE ) treatment of age - related macular degeneration ( AMD ) and other eye disorders. One or more therapeutic agents can be (21 ) Appl. No .: 15 /910 , 992 used to treat any stages ( including the early , intermediate ( 22 ) Filed : Mar. 2 , 2018 and advance stages ) of AMD , and any phenotypes of AMD , including geographic atrophy ( including non -central GA and Related U . S . Application Data central GA ) and neovascularization ( including types 1 , 2 and 3 NV ) . In certain embodiments , an anti - dyslipidemic agent ( 60 ) Provisional application No . 62/ 467 ,073 , filed on Mar . ( e . g . , an apolipoprotein mimetic and / or a statin ) is used 3 , 2017 . alone to treat or slow the progression of atrophic AMD Publication Classification ( including early AMD and intermediate AMD ) , and / or to (51 ) Int. CI. prevent or delay the onset of AMD , advanced AMD and /or A61K 31/ 366 ( 2006 . 01 ) neovascular AMD . In further embodiments , two or more A61P 27 /02 ( 2006 .01 ) therapeutic agents ( e . g ., any combinations of an anti - dys A61K 9 / 00 ( 2006 . 01 ) lipidemic agent, an antioxidant, an anti- inflammatory agent, A61K 31 / 40 ( 2006 .01 ) a complement inhibitor, a neuroprotector and an anti - angio A61K 45 / 06 ( 2006 .01 ) genic agent ) that target multiple underlying factors of AMD A61K 38 / 17 ( 2006 .01 ) ( e .
    [Show full text]
  • Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011
    CLASSIFICATION DECISIONS TAKEN BY THE HARMONIZED SYSTEM COMMITTEE FROM THE 47TH TO 60TH SESSIONS (2011 - 2018) WORLD CUSTOMS ORGANIZATION Rue du Marché 30 B-1210 Brussels Belgium November 2011 Copyright © 2011 World Customs Organization. All rights reserved. Requests and inquiries concerning translation, reproduction and adaptation rights should be addressed to [email protected]. D/2011/0448/25 The following list contains the classification decisions (other than those subject to a reservation) taken by the Harmonized System Committee ( 47th Session – March 2011) on specific products, together with their related Harmonized System code numbers and, in certain cases, the classification rationale. Advice Parties seeking to import or export merchandise covered by a decision are advised to verify the implementation of the decision by the importing or exporting country, as the case may be. HS codes Classification No Product description Classification considered rationale 1. Preparation, in the form of a powder, consisting of 92 % sugar, 6 % 2106.90 GRIs 1 and 6 black currant powder, anticaking agent, citric acid and black currant flavouring, put up for retail sale in 32-gram sachets, intended to be consumed as a beverage after mixing with hot water. 2. Vanutide cridificar (INN List 100). 3002.20 3. Certain INN products. Chapters 28, 29 (See “INN List 101” at the end of this publication.) and 30 4. Certain INN products. Chapters 13, 29 (See “INN List 102” at the end of this publication.) and 30 5. Certain INN products. Chapters 28, 29, (See “INN List 103” at the end of this publication.) 30, 35 and 39 6. Re-classification of INN products.
    [Show full text]
  • Homenagem a August Karl Gustav Bier Por Ocasião Dos 100 Anos Da
    Rev Bras Anestesiol ARTIGO DIVERSO 2008; 58: 4: 409-424 MISCELLANEOUS Homenagem a August Karl Gustav Bier por Ocasião dos 100 Anos da Anestesia Regional Intravenosa e dos 110 Anos da Raquianestesia* Eulogy to August Karl Gustav Bier on the 100th Anniversary of Intravenous Regional Block and the 110th Anniversary of the Spinal Block Almiro dos Reis Jr, TSA1 RESUMO Unitermos: ANESTESIA, Regional: subaracnóidea, venosa; Reis Jr. A — Homenagem a August Karl Gustav Bier por Ocasião dos ANESTESIOLOGIA: história. 100 Anos da Anestesia Regional Intravenosa e dos 110 Anos da Raquianestesia SUMMARY JUSTIFICATIVA E OBJETIVOS: August Karl Gustav Bier foi o in- Reis Jr A — Eulogy to August Karl Gustav Bier on the 100th Anni- trodutor de duas importantes técnicas de anestesia regional: a versary of Intravenous Regional Block and the 110th Anniversary of anestesia regional intravenosa e a anestesia subaracnóidea, Spinal Block. ambas até hoje amplamente empregadas. Completando neste ano de 2008 a primeira delas 100 anos e a segunda 110 anos de exis- BACKGROUND AND OBJECTIVES: August Karl Gustav Bier in- tência, seria mais do que justo prestarmos uma homenagem ao no- troduced two important techniques in regional block: intravenous tável médico que as criou. regional block and subarachnoid block, widely used nowadays. Since the first one celebrates its 100th anniversary and the second CONTEÚDO: O texto relata os dados familiares, estudantis inici- its 110th anniversary, it is only fair that we pay homage to this ex- ais, do curso acadêmico e da residência médica, as atividades pro- traordinary physician who created them. fissionais e universitárias, a personalidade, a aposentadoria e o falecimento de A.
    [Show full text]
  • Annual Report 2018 Medial Faculty Universität Bern
    Medical Faculty www.medizin.unibe.ch Annual Report 2018 CONTENTS Foreword ......................................................................................................................................... 5 Historical A brief history of the Faculty .................................................................................................... 6 Strategy and Numbers Research strategy ................................................................................................................... 10 The Medical Faculty in numbers ............................................................................................. 11 Key people and Institutions Organigram ........................................................................................................................... 12 Key people ............................................................................................................................ 13 Institutional overview ............................................................................................................. 14 Structural development .......................................................................................................... 16 Teaching School of Human Medicine .................................................................................................... 18 School of Dental Medicine ..................................................................................................... 20 Bachelor and Master Program in Pharmacy ...........................................................................
    [Show full text]
  • WO 2017/025588 Al 16 February 2017 (16.02.2017) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/025588 Al 16 February 2017 (16.02.2017) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 9/127 (2006.01) A61K 47/48 (2006.01) kind of national protection available): AE, AG, AL, AM, A61K 31/00 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (21) Number: International Application DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/EP20 16/069 107 HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, (22) International Filing Date: KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, 11 August 2016 ( 11.08.2016) MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, (25) Filing Language: English SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, (26) Publication Language: English TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 2015291 11 August 2015 ( 11.08.2015) NL kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, (71) Applicant: EYESIU MEDICINES B.V.
    [Show full text]
  • WO 2016/003886 Al 7 January 2016 (07.01.2016) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization I International Bureau (10) International Publication Number (43) International Publication Date WO 2016/003886 Al 7 January 2016 (07.01.2016) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/4706 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/US20 15/038287 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 29 June 2015 (29.06.2015) KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, (25) Filing Language: English PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, (26) Publication Language: English SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 62/020,167 2 July 2014 (02.07.2014) (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicant: LAM THERAPEUTICS, INC. [US/US]; 530 GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, Old Whitfield Street, Guilford, CT 06437 (US).
    [Show full text]
  • Apilimod for Use in the Treatment of Renal Cancer
    (19) *EP003581184A1* (11) EP 3 581 184 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 18.12.2019 Bulletin 2019/51 A61K 31/5377 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01) A61K 31/44 (2006.01) (2006.01) (21) Application number: 19171060.7 A61K 31/506 (22) Date of filing: 06.11.2015 (84) Designated Contracting States: • CONRAD, Chris AL AT BE BG CH CY CZ DE DK EE ES FI FR GB Connecticut, Guilford 06437 (US) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO •XU, Tian PL PT RO RS SE SI SK SM TR Connecticut, Guilford 06437 (US) • ROTHBERG, Jonathan M. (30) Priority: 07.11.2014 US 201462077127 P Connecticut, Guilford 06437 (US) • LICHENSTEIN, Henri (62) Document number(s) of the earlier application(s) in Connecticut, Guilford 06437 (US) accordance with Art. 76 EPC: 15795318.3 / 3 215 158 (74) Representative: Haseltine Lake Kempner LLP Lincoln House, 5th Floor (71) Applicant: AI Therapeutics, Inc. 300 High Holborn Guilford, CT 06437 (US) London WC1V 7JH (GB) (72) Inventors: Remarks: • BEEHARRY, Neil •This application was filed on 25.04.2019 as a Connecticut, Guilford 06437 (US) divisional application to the application mentioned • GAYLE, Sophia under INID code 62. Connecticut, Guilford 06437 (US) •Claims filed after the date of filing of the application • LANDRETTE, Sean / after the date of receipt of the divisional application Connecticut, Guilford 06437 (US) (Rule 68(4) EPC). • BECKETT, Paul Connecticut, Guilford 06437 (US) (54) APILIMOD FOR USE IN THE TREATMENT OF RENAL CANCER (57) The present disclosure relates to methods for treating renal cancer with apilimod and related compositions and methods.
    [Show full text]
  • WHO Drug Information Vol
    WHO Drug Information Vol. 25, No. 1, 2011 World Health Organization WHO Drug Information Contents International Harmonization Mometasone furoate/formoterol fumarate: 14th International Conference of Drug withdrawal of marketing authorization Regulatory Authorities 1 application 37 International Conference of Drug Briakinumab: withdrawal of marketing Regulatory Authorities: personal authorization application 37 reminiscences 18 Omacetaxine mepesuccinate: withdrawal of marketing authorization application 38 Zoledronic acid: withdrawal of application WHO Prequalification of for an extension of indication 38 Medicines Programme Pandemic influenza vaccine (H5N1): Inspection of API manufacturing sites 24 withdrawal of marketing authorization application 38 Safety and Efficacy Issues ENCePP launch electronic register ATC/DDD Classification of studies 28 ATC/DDD Classification (temporary) 40 Methysergide and retroperitoneal fibrosis 28 ATC/DDD Classification (final) 43 Clozapine and life-threatening gastro- intestinal hypomotility 29 Recent Publications, Tamoxifen and anti-depressants: drug interaction 30 Information and Events Dronedarone : severe liver injury 31 Assessment of 26 African regulatory Dolasetron mesylate: abnormal heart authorities 46 rhythm 32 Quality of antimalarials in sub-Saharan Sitaxentan: update following withdrawal 32 Africa 46 Bevacizumab use in breast cancer Good governance for medicines 47 treatment 33 EC/ACP/WHO Partnership on Pharma- Latest developments in pharmaco- ceutical Policies 47 vigilance 33 Recommended International
    [Show full text]
  • Stembook 2018.Pdf
    The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances FORMER DOCUMENT NUMBER: WHO/PHARM S/NOM 15 WHO/EMP/RHT/TSN/2018.1 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances. Geneva: World Health Organization; 2018 (WHO/EMP/RHT/TSN/2018.1). Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data.
    [Show full text]
  • (Ernst Werner) Hans Zocher
    URL: http://www.uni-kiel.de/anorg/lagaly/group/klausSchiver/zocher.pdf Please take notice of: (c)Beneke. Don't quote without permission. (Ernst Werner) Hans Zocher (27.04.1893 Bad Liebenstein/Thüringen - 16.10.1969 Rio de Janeiro) Kolloidwissenschaftler, Taktosole Pionier der Flüssigkristalldisplays (LCD) (Nebst der Vorschrift zur Herstellung eines V2O5-Taktosols) Juli 2006 Klaus Beneke Institut für Anorganische Chemie der Christian-Albrechts-Universität D-24098 Kiel [email protected] 2 (Ernst Werner) Hans Zocher (27.04.1893 Bad Liebenstein/Thüringen - 16.10.1969Rio de Janeiro) Kolloidwissenschaftler, Taktosole (V2O5-Sole) Pionier der Flüssigkristalldisplays (LCD) (Nebst der Vorschrift zur Herstellung eines V2O5-Taktosols) Ernst Werner Hans Zocher wurde als Sohn von Emil und Helene Zocher, am 27. April 1893 in Bad Liebenstein1 in Thüringen, geboren. Schon als Kind machte ihn sein Vater, ein Botaniker, mit den Pflanzen und Mineralien der thüringischen Land- schaft bekannt. Nach der Schule studierte Hans Zocher von 1912 bis Burgruine Liebenstein 1914 Chemie, Physik, Mathematik und Mineralogie an den Universitäten Leipzig und Jena. Mit Beginn des Ersten Weltkriegs wurde er zum Militär als Frontkämpfer eingezogen und erlitt 1916 bei Kampfhandlungen sehr schwere Verletzungen, wobei seine linke Gesichtshälfte lebenslang entstellt wurde. Während der Rekonvaleszenz konnte er oftmals ein Mineralogisches Museum besuchen und setzte danach bis 1919 sein Studium an der Universität Berlin fort. Bereits 1917 wurde Hans Zocher Assistent bei Arthur Rosenheim2 und leitete Experimentalkurse der anorganischen und physikalischen 1 Bad Liebenstein liegt im nordwestlichen Thüringer Wald und ist durch Berge und Mischwälder geprägt. Diese und Bergwiesen, sowie der in unmittelbarer Nähe liegende Rennsteig, laden zum Wandern ein.
    [Show full text]
  • Medizingeschichte an Der Universität Bern
    Medizingeschichte an der Universität Bern Von den Anfängen bis 2011 Medizingeschichte an der Universität Bern Von den Anfängen bis 2011 Von Urs Boschung Mit einem Beitrag von Susi Ulrich-Bochsler Bern 2014 In der Schrift «50 Jahre Institut für Medizingeschichte der Universität Bern, 1963-2013», hrsg. von Hubert Steinke, Bern 2013, finden sich Illustrationen zum Thema und eine ge- kürzte Fassung dieses Textes. Umschlag: Titelkupfer von Christian Gottlieb Geyser (1742-1803) zu: Johann Daniel Metzger, «Skizze einer pragmatischen Literärgeschichte der Medicin», Königs berg, bey Friedrich Nicolovius, 1792 (IMG, WZ260 M596) © Institut für Medizingeschichte, Universität Bern, 2013 www.img.unibe.ch Redaktion: Urs Boschung Gestaltung: Hannes Saxer, Grafikatelier Saxer, Bern Druck: Edubook AG, Merenschwand 2 Inhalt Medizinhistorische Praktiker im 19. und 20. Jahrhundert ...................... 7 Medizingeschichte als akademische Disziplin: Henry E. Sigerist ......... 14 Die Gründung der Schweizerischen Fachgesellschaft, 1921 .................. 19 Medizingeschichte an den Schweizer Universitäten ............................... 24 Deutschschweiz .................................................................................... 24 Westschweiz .......................................................................................... 27 Medizingeschichte wird Pflichtfach, 1964 ........................................ 28 Medizingeschichte an der Universität Bern: Die Anfänge ..................... 36 Nebenamtlich tätige Dozenten und Forscher .................................
    [Show full text]
  • Researching Reproduction in Hedgehog Tenrecs (Afrosoricida, Tenrecidae) Carter, Anthony M
    University of Southern Denmark Hans Bluntschli in Berne Researching reproduction in hedgehog tenrecs (Afrosoricida, Tenrecidae) Carter, Anthony M Published in: Journal of Morphology DOI: 10.1002/jmor.20988 Publication date: 2019 Document version: Accepted manuscript Citation for pulished version (APA): Carter, A. M. (2019). Hans Bluntschli in Berne: Researching reproduction in hedgehog tenrecs (Afrosoricida, Tenrecidae). Journal of Morphology, 280(6), 841-848. https://doi.org/10.1002/jmor.20988 Go to publication entry in University of Southern Denmark's Research Portal Terms of use This work is brought to you by the University of Southern Denmark. Unless otherwise specified it has been shared according to the terms for self-archiving. If no other license is stated, these terms apply: • You may download this work for personal use only. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying this open access version If you believe that this document breaches copyright please contact us providing details and we will investigate your claim. Please direct all enquiries to [email protected] Download date: 04. Oct. 2021 Carter Anthony (Orcid ID: 0000-0002-8359-2085) Hans Bluntschli in Berne: researching reproduction in hedgehog tenrecs (Afrosoricida, Tenrecidae) Anthony M. Carter Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, J. B. Winsloews Vej 21, DK-5000 Odense, Denmark Correspondence Anthony M. Carter, Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, J. B. Winsloews Vej 21, DK-5000 Odense, Denmark. Email: [email protected] Research Highlights Tenrec reproduction was the main aspect of Bluntschli’s research after was obliged to leave Frankfurt for Berne His group described unique features that included non-antral follicles, intraovarian fertilization and absence of a morula stage Abstract The Swiss anatomist Hans Bluntschli is best known as a primatologist.
    [Show full text]